NeuroCIM Research Digest

Pharmacodynamic, patient-selection, and target-engagement biomarkers address core CNS drug development failures by confirming mechanism activity...

Gut-derived metabolites and barrier signals may regulate neuronal energy metabolism, mitochondrial function, and proteostasis in Alzheimer’s and...

Human brain organoids transplanted into mice survive, integrate with host circuitry, and enable study of patient-derived genetic effects on...

Viz.ai's integration of NeuroQuant and NeuroQuant MS into its platform extends quantitative MRI analysis from specialist use to coordinated care...

The CAG-CCG loss-of-interruption variant triggers Huntington’s disease onset up to 12.5 years earlier by driving up to fivefold greater HTT expansions...

Locus coeruleus neurons, long viewed as a pain-suppression system, instead sustain chronic hypersensitivity after nerve injury when local mu opioid...

Does brighter daytime light causally lower dementia risk, or does the observational data mainly reflect healthier behaviors and circadian patterns?

-...

Novartis halted VHB937 (lifonebart), a TREM2 stabilizer targeting immune responses, inflammation, and brain waste clearance, after it missed both...

CB1 and CB2 receptors mediate Cannabis sativa effects on oxidative stress, reactive gliosis, and neuroinflammation—the core pathophysiological hallmarks of neurodegenerative disease.

• LRRK2 is directly linked to Parkinson’s pathogenesis, yet Type 1 inhibitors showed pulmonary findings in preclinical studies
• 1ST-104 uses a Type 2...

The $21M five-year NIH award sustains the Cleveland Alzheimer’s Disease Research Center’s multi-institutional framework, uniting clinicians and...

Duke's EGFRvIII-BRiTE is engineered to cross the blood-brain barrier and redirect patient T-cells to attack glioblastoma cells expressing the...

CAAR-T 细胞通过双特异性受体选择性清除致病性B细胞，避免传统广谱免疫抑制或常规CAR-T的非特异性损伤。

• 选择性机制：CAAR-T 仅靶向携带自身抗体的B细胞，保留正常免疫功能，优于现有疗法。
• 鼠模型验证：已在重症肌无力与抗NMDA受体脑炎模型中证明可消除多样B细胞群体。
• 临床转化安全问题：需解决GMP级生产与质量控制，目前仍处实验室阶段。

NF2 clinical trials have historically lacked consensus on measuring hearing loss and facial weakness, key morbidities from vestibular schwannomas that...

Biological, imaging, digital and wearable biomarkers are transforming early detection and trial efficiency in Alzheimer's, Parkinson's and related...

• UCL团队将痴呆MRI扫描时间从18分钟缩短至6.5分钟，维持诊断质量，显著减轻患者负担。
• 快速扫描提升NHS容量，每小时可检查3-4名患者，增强诊断可及性。
• p-tau217血液检测正从专科影像转向便捷早期筛查，减少侵入性检查。

Drug development targets cellular weaknesses via pre-clinical testing then human trials to confirm efficacy. Recent examples include phase 1 AAV gene...

What can Mendelian randomization tell us about GLP-1 receptor activation and psychiatric risk?

• Stronger benefits than weight loss alone:...

• Core insight: NEC in preterm infants triggers neurodevelopmental impairment through gut-derived inflammation, exceeding prematurity risks alone
  -...

At RAPS Convergence 2026, FDA and EMA leaders stressed that representative enrollment now centers on generating reliable evidence for intended...